Concepedia

Author

Yvonne Kienast

Roche Pharma AG (Germany)ORCID

Also Known As

Kienast, Yvonne, Y Kienast, Yvonne Kienast, Yvonnne Kienast

61

Publications

3.5K

Citations

16

H-Index

49

Concepts

All Affiliations

Roche Pharma AG (Germany)Roche (Switzerland)Ludwig-Maximilians-Universität MünchenUniversity Hospital HeidelbergHeidelberg University
YK

About

Yvonne Kienast is an author at Roche Pharma AG (Germany) specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

2K

2

Cell Biology

6

6

904

3

Engineering

2

2

1.2K

4

Health Sciences

1

1

36

5

Biomedical Engineering

1

1

36

Yvonne Kienast

×

18

Publications

3.4K

Citations

15

H-Index

YearCitations

Real-time imaging reveals the single steps of brain metastasis formation

Yvonne Kienast, Louisa von Baumgarten, Martin Fuhrmann,

Nature Medicine

2009

1.1K

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade

Martina Schmittnaegel, Nicolò Rigamonti, Ece Kadioglu,

Science Translational Medicine

2017

564

Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling

Moritz Felcht, Robert Luck, Alexander Schering,

Journal of Clinical Investigation

2012

466

Imaging glioma cell invasion <i>in vivo</i> reveals mechanisms of dissemination and peritumoral angiogenesis

Frank Winkler, Yvonne Kienast, Martin Fuhrmann,

Glia

2009

217

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

Sabine Hoves, Chia-Huey Ooi, Carsten Wolter,

The Journal of Experimental Medicine

2018

205

Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy

Yvonne Kienast, Christian Klein, Werner Scheuer,

Clinical Cancer Research

2013

197

Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells

Louisa von Baumgarten, David Brucker, Anca Tirniceru,

Clinical Cancer Research

2011

162

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy

Abhishek S. Kashyap, Martina Schmittnaegel, Nicolò Rigamonti,

Proceedings of the National Academy of Sciences

2019

86

TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma

Virginia Egea, Louisa von Baumgarten, Cristian Schichor,

Cell Death and Differentiation

2010

83

Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma

Chaobo Hu, Weiping Li, Feng Tian,

Journal of Hepatology

2017

71

Page 1